Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity

Diabetes Care

Volumn 30, Issue 4, 2007, Pages 939-945

  Esteve, Eduardo ^a,b   Castro, Antoni ^a,b   López Bermejo, Abel ^a,b   Vendrell, Joan ^c   Ricart, Wifredo ^a,b   Fernández Real, Jose Manuel ^a,b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUTRAL INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INSULIN; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; VASODILATION;

EID: 34147092226     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1793     Document Type: Article

References (35)

1. Fernandez-Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301, 2003
2. Vila E, Salaices M: Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 288:1016-1021, 2005
3. Ridker PM, Rifai N, Pfeffer M, Saks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-2153, 2002
4. Engstrom G, Hedblad B, Stavenow L, Tyden P, Lind P, Janzon L, Lindgarde F: Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation 110:27-31, 2004
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
6. Pradham AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifi N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM: Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288:980-987, 2002
7. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772, 2000
8. Esteve E, Ricart W, Fernandez-Real JM: Dyslipidemia and inflammation: an evolutionary mechanism. Clin Nutr 24:16-31, 2005
9. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214, 2000
10. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
11. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 54:1-78, 1993
12. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82:4196-4200, 1997
13. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695, 2005
14. Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. Diabetologia 45:623-634, 2002
15. Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca L, Ferrannini E: Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 55:1133-1140, 2006
16. Widlansky ME, Gokce N, Keaney JF, Vita JA: The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42:1149-1160, 2003
17. Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Perez A, Richart C, Engel P, Ricart W: Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 282:952-959, 2002
18. Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, Hu FB: A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28:1376-1382, 2005
19. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599-610, 2004
20. Woods A, Brull DJ, Humphries SE, Montgomery HE: Genetics of inflammation and risk of coronary artery disease: the central role of interleukin 6. Eur Heart J 21:1574-1583, 2000
21. Fernández-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W: Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159, 2001
22. Chan JCN, Cheung JCK, Stehouwer CDA, Emeis JJ, Tong PCY, Ko GTC, Yudkin JS: The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome-an analysis by structural equation modeling. Int J Obes 26:994-1008, 2002
23. Loppnow H, Libby P: Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. Lymphokine Res 8:293-299, 1989
24. Verma S, Wang Ch, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913-919, 2002
25. Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska I, Lehman BT, Fan S, Osypiuk E, Wilson PW, Vasan RS, Mitchell GF, Benjamin EJ: Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 110:3604-3609, 2004
26. Lee K, Blann AD, Lip GY: Inter-relationships of indices of endothelial damage/dysfunction (circulating endothelial cells, von Willebrand factor and flow-mediated dilatation) to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 111:302-308, 2006
27. Nawawi H, Osman NS, Annuar R, Khalid BA, Yusoff K: Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. Atherosclerosis 169:283-291, 2003
28. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066-3072, 2005
29. Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad MF, Selby JV, Bergman R, Savage P: Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27:781-787, 2004
30. Pasimeni G, Ribaudo MC, Capoccia D, Rossi F, Bertone C, Leonetti F, Santiemma V: Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: relationship with insulin resistance. Microvasc Res 71:115-120, 2006
31. Ardigo D, Franzini L, Valtuena S, Monti LD, Reaven GM, Zavaroni I: Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers. Am J Cardiol 97:1250-1254, 2006
32. Horio T, Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Yoshimasa Y, Kawano Y: Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension. Am J Hypertens 18:1626-1630, 2005
33. Esposito K, Ciotola M, Carleo D, Schisano B, Saccomanno F, Sasso FC, Cozzolino D, Assaloni R, Merante D, Ceriello A, Giugliano D: Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. Diabetes Care 29:1071-1076, 2006
34. Utriainen T, Makimattila S, Virkamaki A, Bergholm R, Yki-Jarvinen H: Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia 39:1477-1482, 1996
35. Tack CJ, Ong MK, Lutterman JA, Smits P: Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance: effects of troglitazone. Diabetologia 41:569-576, 1998